Our current study investigated the longitudinal association between early cMD at baseline and longitudinal evolution of regional tau accumulation and episodic memory performance in cognitively asymptomatic participants at risk for AD as defined by their amyloid status. This evidence concerns the gene MAPT and amyloidosis.